Yen FS, Hwu CM, Liu JS, Wu YL, et al. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease. Ann Intern Med 2024 Apr 30. doi: 10.7326/M23-1874.
PMID: 38684099